Utility of Intravitreal Methotrexate in Diabetic Macular Edema Resistant to Conventional Therapies
Status:
Terminated
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
It is well known that blindness is one of the most feared disabilities expressed by patients
in the United States. Estimates of the economic impact of visual disability in the current
population exceed 30 million US dollars in this country alone. The reasons for this figure
are many; however age related macular degeneration (ARMD), diabetic retinopathy, glaucoma and
uveitis are responsible for the majority of permanent visual disability and hence the costs
in both quality of life and placing an economic burden on society. Research that may help
reverse various abnormal biological responses that lead to or worsen clinical manifestations
of diabetic retinopathy would be valuable.
Phase:
N/A
Details
Lead Sponsor:
Wake Forest School of Medicine Wake Forest University